Broadcast Date: Friday, September 16, 2022
from 3:00 pm to 4:00 pm (ET)


In light of the changing landscape of securities litigation, staying current has become crucial to many businesses and organizations today. Notably, the past months have seen a significant rise in case filings involving special purpose acquisition company (SPAC), cryptocurrencies, and COVID-19. The latest court decisions are also expected to bring drastic changes to the regulatory and litigation landscape. Hence, to avoid pitfalls, keeping abreast of the key developments and critical issues are paramount in developing new litigation strategies.

In this LIVE Webcast, distinguished securities expert Dr. Paul Zurek (Cornerstone Research) and securities and corporate governance litigator David Priebe (DLA Piper LLP) will present the audience with the latest developments in securities litigation. The speakers will also share an in-depth analysis of the potential implications of notable court rulings as well as practical tips and strategies to successfully win this type of lawsuit.

Key topics that will be covered in this discussion are:

  • Securities Litigation: Recent Trends and Statistics
  • Notable Cases and Court Decisions
  • Key Enforcement Priorities
  • Critical Issues and Challenges
  • Best Litigation Strategies
  • Regulatory Outlook


Course Level:



Advance Preparation:

Print and review course materials


Method of Presentation:

Live Webcast



General knowledge of securities litigation


Course Code:



NY Category of CLE Credit:

Areas of Professional Practice


Total Credit:

1.0 CLE

Speaker Panel:

Paul Zurek, Vice President
Cornerstone Research

Paul Zurek specializes in matters related to markets, securities litigation, risk management, valuation, and complex data analysis. He has submitted expert reports and declarations and testified in arbitration and regulatory investigations. In addition to serving as an expert, Dr. Zurek leads large teams in government and regulatory inquiries, civil litigation, and international arbitration. He has supported academic and industry experts at all stages of litigation, including trial.

Dr. Zurek’s econometric and financial expertise spans a range of industries, including investment management and financial institutions, technology, telecommunications, and transportation.

David Priebe, Partner

David Priebe is a securities and corporate governance litigator and advisor with over 30 years’ experience defending companies, officers and directors in securities class action and shareholder derivative lawsuits.  David focuses on innovative substantive and jurisdictional arguments and policies and publishes an Internet site,, containing articles on these topics topics.


Segment 1

Paul ZurekVice President

Cornerstone Research

  • Recent trends in securities class action filings
  • Recent trends in securities class action settlements, including settlements in parallel shareholder derivative actions


Segment 2

David Priebe, Partner


  • Event-driven litigation
  • Increasing significance of social media
  • Increasing significance of short-sellers
  • Coming (ESG) and going (SPAC) types of litigation
  • Omnicare (opinions)
  • Puffery
  • Other interesting anti-falsity arguments
  • Interesting anti-scienter arguments
  • Safe Harbor
  • Duty to disclose SEC investigations (Noto)
  • Lorenzo and scheme liability
  • New key Dodd-Frank whistleblower decision (Murray)
  • Delaware bylaws requiring federal court Securities Act litigation (Restoration Robotics)
  • Loss causation
  • Class certification incl. Goldman Sachs

Date & Time:

Friday, September 16, 2022

3:00 pm to 4:00 pm (ET)

Who Should Attend:

  • Compliance Officers
  • Corporate Lawyers
  • General Counsel
  • M&A Lawyers
  • Securities Litigation Attorneys
  • Top Level Management


Paul ZurekVice President
Cornerstone Research
David PriebePartner



View Details


View Details


View Details

Join Over 150,000 Professionals Empowering Their Careers

Learn anywhere from over 1900+ live and recorded CLE, CPE & Technology Webcasts.